Want to see JP:4579 full AI Analyst Report?
Total Valuation
RaQualia Pharma Inc. has a market cap or net worth of ¥15.46B. The enterprise value is ¥10.30K.
Market Cap¥15.46B
Enterprise Value¥10.30K
Share Statistics
RaQualia Pharma Inc. has 26,031,412 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding26,031,412
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RaQualia Pharma Inc.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.07%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.07%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee46.82M
Profits Per Employee3.21M
Employee Count85
Asset Turnover0.38
Inventory Turnover4.46
Valuation Ratios
The current PE Ratio of RaQualia Pharma Inc. is 66.4. RaQualia Pharma Inc.’s PEG ratio is -0.58.
PE Ratio66.4
PS Ratio6.01
PB Ratio3.47
Price to Fair Value3.47
Price to FCF-56.43
Price to Operating Cash Flow30.94
PEG Ratio-0.58
Income Statement
In the last 12 months, RaQualia Pharma Inc. had revenue of 3.98B and earned 273.12M in profits. Earnings per share was 11.53.
Revenue3.98B
Gross Profit3.27B
Operating Income483.72M
Pretax Income437.95M
Net Income273.12M
EBITDA985.17M
Earnings Per Share (EPS)11.53
Cash Flow
In the last 12 months, operating cash flow was 499.45M and capital expenditures -40.66M, giving a free cash flow of 458.80M billion.
Operating Cash Flow499.45M
Free Cash Flow458.80M
Free Cash Flow per Share17.62
Dividends & Yields
RaQualia Pharma Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change2.06%
50-Day Moving Average521.14
200-Day Moving Average762.34
Relative Strength Index (RSI)67.58
Average Volume (3m)141.95K
Important Dates
RaQualia Pharma Inc. upcoming earnings date is Nov 6, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 6, 2026
Ex-Dividend Date―
Financial Position
RaQualia Pharma Inc. as a current ratio of 4.46, with Debt / Equity ratio of 34.30%
Current Ratio4.46
Quick Ratio4.33
Debt to Market Cap0.11
Net Debt to EBITDA-0.34
Interest Coverage Ratio8.19
Taxes
In the past 12 months, RaQualia Pharma Inc. has paid 164.83M in taxes.
Income Tax164.83M
Effective Tax Rate0.38
Enterprise Valuation
RaQualia Pharma Inc. EV to EBITDA ratio is 23.94, with an EV/FCF ratio of -55.63.
EV to Sales5.93
EV to EBITDA23.94
EV to Free Cash Flow-55.63
EV to Operating Cash Flow-66.14
Balance Sheet
RaQualia Pharma Inc. has ¥4.70B in cash and marketable securities with ¥2.69B in debt, giving a net cash position of ¥2.01B billion.
Cash & Marketable Securities¥4.70B
Total Debt¥2.69B
Net Cash¥2.01B
Net Cash Per Share¥77.23
Tangible Book Value Per Share¥133.54
Margins
Gross margin is 79.46%, with operating margin of 12.15%, and net profit margin of 6.86%.
Gross Margin79.46%
Operating Margin12.15%
Pretax Margin11.00%
Net Profit Margin6.86%
EBITDA Margin24.75%
EBIT Margin12.49%
Analyst Forecast
The average price target for RaQualia Pharma Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast20.64%
EPS Growth Forecast―